SLC1A2 and Parkinson disease: In this study, we aimed to examine the effect of RBD on the rate of cognitive decline in PD patients and investigate whether plasma levels of the neuroexosomal glutamate transporters VGLUT-1 and EAAT-2 are altered in PD patients with RBD.